Golden State Equity Partners Mirum Pharmaceuticals, Inc. Transaction History
Golden State Equity Partners
- $491 Million
- Q1 2025
A detailed history of Golden State Equity Partners transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Golden State Equity Partners holds 19,380 shares of MIRM stock, worth $842,061. This represents 0.18% of its overall portfolio holdings.
Number of Shares
19,380
Previous 19,380
-0.0%
Holding current value
$842,061
Previous $801,000
8.99%
% of portfolio
0.18%
Previous 0.16%
Shares
9 transactions
Others Institutions Holding MIRM
# of Institutions
217Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$285 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$199 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$141 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$122 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$113 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.6B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...